Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
35
35 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- AzetukalnerXEN1101Phase 39 trials
Xenon Pharmaceuticals Inc. · Focal Onset Seizures, Major Depressive Disorder, Bipolar Disorder
- SEP-363856UlotarontPhase 37 trials
Otsuka · Generalized Anxiety Disorder, Schizophrenia, Major Depressive Disorder
- BHV-7000Phase 36 trials
Biohaven Therapeutics Ltd. · Focal Epilepsy, Major Depressive Disorder, Bipolar Disorder
- NBI-1065845TAK-653, OsavampatorPhase 35 trials
Neurocrine Biosciences · Major Depressive Disorder
- CYM-53093Navacaprant, NMRA-335140Phase 34 trials
Neumora Therapeutics, Inc. · Major Depressive Disorder, Major Depressive Episode Associated With Bipolar II Disorder
- DT120MM120, lysergide tartratePhase 34 trials
Definium Therapeutics US, Inc. · Generalized Anxiety Disorder, Major Depressive Disorder
- KH607Phase 34 trials
Chengdu Kanghong Pharmaceutical Group Co., Ltd. · Major Depressive Disorder (MDD), Postpartum Depressive Disorder
- PsilocybinCOMP360Phase 34 trials
COMPASS Pathways · Treatment Resistant Depression, Major Depressive Disorder, Anorexia Nervosa
- CYB003Phase 33 trials
Cybin IRL Limited · Major Depressive Disorder, Major Depressive Disorder (MDD), Depression in Adults
- SeltorexantJNJ 42847922Phase 32 trials
Johnson & Johnson (Janssen) · Depressive Disorder, Major
- Bupropion Sustained-ReleasePhase 31 trial
CSPC Ouyi Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)
- ONO-1110Phase 25 trials
Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD
- ABX-002Phase 22 trials
Autobahn Therapeutics, Inc. · Major Depressive Disorder, Bipolar Disorder Depression
- BI 1569912Phase 22 trials
Boehringer Ingelheim · Depressive Disorder, Major
- DT-101Phase 22 trials
Draig Therapeutics Ltd · Major Depressive Disorder (MDD)
- IcalcaprantABBV-1354, CVL-354Phase 22 trials
AbbVie · Bipolar I Disorder, Bipolar II Disorder, Major Depressive Disorder
- SPT-300LYT-300, GlyphAlloPhase 22 trials
Seaport Therapeutics · Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
- ZelquistinelGATE-251Phase 22 trials
Syndeio Biosciences, Inc · Major Depressive Disorder
- ACP-211Phase 21 trial
ACADIA Pharmaceuticals Inc. · Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant
- ALTO-100Phase 21 trial
Alto Neuroscience · Bipolar Disorder I or II With a Major Depressive Episode
- ALTO-203Phase 21 trial
Alto Neuroscience · Major Depressive Disorder, Anhedonia
- ALTO-300Phase 21 trial
Alto Neuroscience · Major Depressive Disorder
- BMS-986511EvifacotrepPhase 21 trial
Bristol Myers Squibb · Major Depressive Disorder
- CLE-100Phase 21 trial
Clexio Biosciences Ltd. · Adjunctive Treatment of Major Depressive Disorder (MDD)
- ELE-101Phase 21 trial
Eleusis Therapeutics · Healthy Volunteers, Major Depressive Disorder, Depression
- GM-1020Phase 21 trial
Gilgamesh Pharmaceuticals · Major Depressive Disorder
- GM-2505Phase 21 trial
AbbVie · Major Depressive Disorder
- JNJ-89495120Phase 21 trial
Johnson & Johnson (Janssen) · Depressive Disorder, Major
- NBI-1070770Phase 21 trial
Neurocrine Biosciences · Major Depressive Disorder
- NH102Phase 21 trial
Jiangsu Nhwa Pharmaceutical Co., Ltd. · Major Depressive Disorder (MDD)
- PDC-1421Phase 21 trial
BioLite, Inc. · Major Depressive Disorder
- PRT042Phase 21 trial
Sichuan Purity Pharmaceutical Technology Co., Ltd. · Major Depressive Disorder (MDD
- SP-624Phase 21 trial
Sirtsei Pharmaceuticals, Inc. · Major Depressive Disorder
- SPN-821Phase 21 trial
Supernus Pharmaceuticals, Inc. · Major Depressive Disorder (MDD)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.